5 High-Growth Markets Where You Can Build Substantial Wealth in 2026
Here are five emerging markets poised for breakout growth in 2026.
OpenAI has trained its LLM to confess to bad behavior
OpenAI is testing another new way to expose the complicated processes at work inside large language models. Researchers at the company can make an LLM produce what they call a confession, in which the model explains how it carried out a task and (most of the time) owns up to any bad behavior. Figuring out…
TopTechTrends
Why My Need to Control Everything Was Holding My Team Back
When the most dependable person in the room becomes the bottleneck, growth stalls.
Spend Less and Stay Productive with This MacBook Air for Less Than $250
Solid performance for anyone on a budget.
I Failed My First Startup — Here’s How I Pivoted Without Losing Momentum
Through all my pivots, one thing became clear: maintaining momentum depends on having options
SoftBank stays in as Meesho $606M IPO becomes India’s first major e-commerce listing
Meesho heads for India’s first big e-commerce IPO next week.
How OpenAI and Google see AI changing go-to-market strategies
AI is changing how investors and startups bring their products to market. Three experts offered their insights at TechCrunch Disrupt.
The race to regulate AI has sparked a federal vs state showdown
The fight over AI regulation isn’t about the technology — it’s about whether Washington or the states get to set the rules, and what happens to consumers caught in between.
Microsoft Office for Windows Drops to Less Than $35 to Support Smoother Business Workflows
This lifetime license deal saves you $185.
The Download: the mysteries surrounding weight-loss drugs, and the economic effects of AI
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. What we still don’t know about weight-loss drugs Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind Mounjaro and Zepbound, became the first…
What we still don’t know about weight-loss drugs
Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind the drugs Mounjaro and Zepbound, became the first healthcare company in the world to achieve a trillion-dollar valuation. Those two drugs, which are prescribed for diabetes and obesity respectively, are generating billions of dollars in revenue for…